Investors are buying shares of Torrent Pharmaceuticals after a media report suggests that private equity firm ChrysCapital has invested around USD 40 million in company. The stock gained as much as 4 percent intraday Thursday. "ChrysCapital, which has over USD 2.5 billion assets under management in India, will hold the largest non-promoter stake of around 3 percent in the drug firm," report said quoting unnamed sources. The promoter and promoter group held 71.51 percent stake in the company as of December 2013 while in non-promoter group, Lavender Investments and Franklin Templeton Investment Funds held 3.31 percent equity shareholding. Torrent is a dominant player in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infectives and pain management.
No comments:
Post a Comment